With 4 global laboratory locations, Q2 Solutions offers a range of next generation sequencing services to support drug discovery, precision medicine, and clinical development. We offer expertise in assay design, development, and validation, plus a translational genomics team comprised of both assay development and bioinformatic scientists, who lead the industry in high complexity testing and analysis. Q2 Solutions offers the following next generation sequencing services:
Service | Capability |
---|---|
Exome Sequencing |
|
RNA Sequencing | Capabilities include:
|
Whole Genome Sequencing | Optimized method for FFPE and intact material, using low input and minimal amplification |
DNA and RNA Isolations | DNA and RNA extraction capabilities from a large spectrum of original material, including FFPE, blood, tissue, and cells |
ThermoFisher in Ion Torrent AmpliSeq and Oncomine Panels |
|
NanoString nCounter Panels |
|
Bioinformatics |
|
If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...
Rules-Based Medicine, a Q2 Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...
TruCulture from Rules-Based Medicine, a Q2 Solutions’ company, provides an innovative whole blood collection and culture system for clinical trials. TruCulture provides a standardized option that...